
    
      Prospective randomized, double-blind, placebo-controlled, single-center trial. Patients
      admitted to ICU after complicated cardiac surgery, major trauma with or without brain injury,
      subarachnoid hemorrhage, and predicted by the clinicians to require >48 hours of ICU
      treatment.

      Supplements: provided IV for 5 days
    
  